WO1998023243A2 - Composition cosmetique, pharmaceutique a base de cultures microbiennes en melange avec une huile essentielle et un acide - Google Patents
Composition cosmetique, pharmaceutique a base de cultures microbiennes en melange avec une huile essentielle et un acide Download PDFInfo
- Publication number
- WO1998023243A2 WO1998023243A2 PCT/FR1997/002127 FR9702127W WO9823243A2 WO 1998023243 A2 WO1998023243 A2 WO 1998023243A2 FR 9702127 W FR9702127 W FR 9702127W WO 9823243 A2 WO9823243 A2 WO 9823243A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- essential oil
- acid
- bacteria
- juice
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Definitions
- Cosmetic, pharmaceutical composition based on microbial cultures mixed with an essential oil and an acid.
- Document EP-0 043 128 B1 discloses a cosmetic composition based on a "complex" of active substances promoting the process of repairing the DNA of skin cells based on an inactivated culture of bacteria of the bifldobacterium genus or bacteria related to this genus (see claim 1 and description).
- This document describes a DNA repair effect demonstrated by comparative tests where the DNA of tissues is damaged in vitro or in vivo by a UV lamp and where it is demonstrated that the complex of active substances formed by inactivated cultures of bifldobacterium produces a significant restorative effect.
- This document also contains various exemplary embodiments in which this complex is used in combination with various mixtures of high molecular weight esters, some of which may be alcoholic esters of citric acid.
- the present inventor has mixed an inactivated culture of bifldobacterium or bacteria related to this genus with an essential oil as well as an acid, preferably organic, in particular a fatty acid, such as citric acid, and demonstrated the unexpected obtaining of a significant anti-wrinkle effect as well as a significant effect of exfoliation of old scars.
- an acid preferably organic, in particular a fatty acid, such as citric acid.
- flower pollen which contains a large number of fermentation microorganisms or ferments, or of its aqueous or organic extracts, in particular lipid extracts, collected by bees or not, unfermented or fermented, constitutes an active ingredient of a composition cosmetic or pharmaceutical, in particular having an anti-wrinkle effect, smoothing, improving the skin texture, lightening, reducing scars, superficial hydrating of the skin, softening for the skin, perfuming, regenerating of the skin.
- the pollen was combined with an essential oil of plant, in particular with an essential oil of mint, preferably peppery, rosemary, lemon and again if this combination was also carried out with an acid, preferably organic, in particular a fatty acid.
- the aforementioned acid is chosen from citric acid used as such or in the form of a derivative such as a salt or ester and in particular an alcoholic ester, or a citrus juice such as lemon juice, orange, lime juice, grapefruit juice, clementine juice, tangerine juice, or an essential oil of lemon or orange or other extracts rich in citric acid or tartaric acid, or ascorbic acid or lactic acid.
- a microbial culture compatible in cosmetics or in pharmacy in particular a culture of microorganisms chosen from acetic or lactic bacteria, lyophilized yeasts, suspensions of microorganisms, fermented organic materials, by example of preferably fermented pollen, or an inactivated culture of bacteria of the bifldobacterium genus or related bacteria of this genus, constitutes an active principle of a cosmetic or pharmaceutical composition, having the above-mentioned activities which are particularly potent when mixed with an oil essential and an acid.
- the present invention relates to the use of a microbial culture compatible in cosmetics or in pharmacy, in particular a culture of microorganisms chosen from acetic or lactic bacteria, lyophilized yeasts, suspensions of microorganisms, fermented organic matter, for example preferably fermented pollen, or an inactivated culture of bacteria of the genus bifldobacterium or of bacteria related to this genus mixed with an essential oil and an acid, preferably organic acid, in particular a fatty acid, as a cosmetic agent or for the preparation of a pharmaceutical composition, in particular with skin regeneration activity, in particular anti-wrinkle, for exfoliation of old scars, for repairing scars left by burns, for promoting skin scarring, for eliminating of spots pigments and also for promoting the growth or regrowth of the integuments, including the nails and the hair.
- a microbial culture compatible in cosmetics or in pharmacy in particular a culture of microorganisms chosen from acetic or lactic bacteria, lyophil
- the present invention also covers a cosmetic or pharmaceutical composition, characterized in that it comprises a microbial culture compatible in cosmetics or in pharmacy, in particular a culture of microorganisms chosen from acetic or lactic acid bacteria, lyophilized yeasts , suspensions of microorganisms, fermented organic materials, for example preferably fermented pollen, or an inactivated culture of bacteria of the genus bifldobacterium or of bacteria related to this genus, mixed with an essential oil and an acid, preferably organic , especially a fatty acid.
- a microbial culture compatible in cosmetics or in pharmacy in particular a culture of microorganisms chosen from acetic or lactic acid bacteria, lyophilized yeasts , suspensions of microorganisms, fermented organic materials, for example preferably fermented pollen, or an inactivated culture of bacteria of the genus bifldobacterium or of bacteria related to this genus, mixed with an essential oil and an acid, preferably organic ,
- the aforementioned microbial culture is used at a concentration of microorganisms of at least 1 million, better still at least 10 million per gram of culture of microorganisms.
- culture is meant the raw culture media or those resulting from a physical separation such as filtration, centrifugation, which are well known to those skilled in the art and which are also described below in relation to pollen. .
- This microbial culture can consist of approximately 1 to approximately 90% by weight of the final composition but generally may vary in preferred concentrations as indicated according to the variants below.
- citric acid as such or in the form of a derivative such as a salt or ester and in particular an alcoholic ester, or a citrus juice, such as lemon juice, orange juice, lime juice, grapefruit juice, clementine juice, tangerine juice, or an essential oil of lemon or orange or other extracts rich in citric acid or tartaric acid, or ascorbic acid or lactic acid.
- the acid can also be a fatty acid compatible in cosmetics or in pharmacy, well known to those skilled in the art. It appeared that the presence of this acid improves the effect in a synergistic way, within the framework of all the activities observed.
- This essential oil is at least one plant essential oil chosen from the group consisting of a mint essential oil, a rosemary essential oil, a thyme essential oil and a cerpolet essential oil, or any of their mixture.
- this essential oil is an essential oil of mint.
- the total essential oil content will preferably vary between about 0.5 and about 10% by weight and more preferably between about 1 and about 7% by weight.
- proteins in particular structural proteins such as collagen or elastin, in particular their soluble forms and also the hydrolysates of such proteins.
- the addition of these proteins increases the resistance of the skin to the treatment.
- the present invention also covers a cosmetic, pharmaceutical or therapeutic treatment method, characterized in that it comprises the administration to a mammal, in particular a human being or an animal, of an effective amount of a microbial culture compatible in cosmetics or pharmacy or therapy, in particular a culture of microorganisms chosen from acetic or lactic acid bacteria, lyophilized yeasts, suspensions of microorganisms, fermented organic matter, for example preferably fermented pollen, or alternatively a inactivated culture of bacteria of the genus bifldobacterium or of bacteria related to this genus in admixture with an essential oil, and of an acid, preferably organic, in particular of a fatty acid.
- Advantageous characteristics of this process also emerge clearly from the advantageous characteristics previously described, in particular with respect to the use as acid of citric acid, with the possible incorporation of another essential oil in particular of an essential oil of rosemary, with the proportions indicated.
- a moisturizing agent is applied, for example serum.
- a moisturizing agent for example serum.
- a concentrated complex of active agents bringing to the epidermis all the essential biological elements. It can be a composition containing, for example, an extract algae, aloe vera, hyaluronic acid, thymus extract, hydroforte, taken alone or as a mixture.
- the present invention also covers the use of flower pollen, or of its aqueous or organic extracts, in particular lipid extracts, as a cosmetic agent or for the preparation of a pharmaceutical composition, in particular having a regeneration activity.
- the skin in particular anti-wrinkle, from exfoliation of old scars, repair of scars left by burns, promotion of cutaneous scarring, elimination of pigment spots, allowing a lightening of the skin, superficial hydration of the skin, skin softening, perfume.
- the pollen from flowers of the aqueous or organic extracts can be used according to the present invention also for the implementation of any of the other aspects of the aforementioned invention.
- the use of flower pollen or of its aqueous or organic extracts, in particular lipid extracts constitutes an invention which is independently patentable from the other aspects of the invention.
- pollen from flowers or from its aqueous or organic extracts, in particular lipid extracts, in the state harvested by the bees, or harvested independently, also in the state unfermented or naturally fermented or enriched with lactic ferments, for example bacteria and / or yeasts, in particular yeasts which can be isolated from pollen or from the bee.
- the flower pollen of the invention may itself be used in lyophilized form or else it may have been concentrated by a physical method such as, for example, centrifugation or filtration.
- the organic extract is advantageously an alcoholic or hydroalcoholic extract with a lower C ⁇ -C 6 alcohol, in particular with ethanol, in the case of a water / alcohol mixture, the concentration of alcohol is generally 40 to 60% by weight.
- this fermentation of the pollen can be followed by maceration with at least one essential oil and / or in the presence of an acid, preferably organic, in particular a fatty acid, preferably of a few hours and advantageously between approximately 1 hour and approximately 6 hours, at a non-critical temperature which can be ambient temperature generally between approximately 0 ° C. and 50 ° C. It should be noted that this maceration stops the previous fermentation process.
- an acid preferably organic, in particular a fatty acid, preferably of a few hours and advantageously between approximately 1 hour and approximately 6 hours
- a non-critical temperature which can be ambient temperature generally between approximately 0 ° C. and 50 ° C.
- any essential oil of plants can be used and an essential oil of mint, in particular peppermint, rosemary, lemon, and mixtures thereof is currently preferred.
- a vegetable oil of first cold pressing such as sunflower oil or soybean
- an oil extracted from pollen for example by an organic solvent, by pressure or by CO 2 supercritical.
- agents providing a so-called texturing texture with the pollen, such as propylene glycol, polyvinyl alcohol, glycerol, polyvinylpyrrolidone, a gelling agent such as xanthan, pectin, an alginate, agar gum, without limitation. , for example carbopol.
- the present invention also covers a cosmetic or pharmaceutical composition, characterized in that it comprises, as active principle, pollen from preferably fermented flowers or from its aqueous or organic extracts, in particular lipid extracts, as defined above, alone or in combination with the other active ingredients mentioned above.
- the present invention also covers a cosmetic, pharmaceutical or therapeutic treatment method, characterized in that it comprises the administration to a mammal, in particular a human being or an animal, of an effective amount of a pollen of preferably fermented flowers, or of its aqueous or organic extracts, in particular lipid extracts, for the desired cosmetic, pharmaceutical or therapeutic effect.
- a cosmetic, pharmaceutical or therapeutic treatment method characterized in that it comprises the administration to a mammal, in particular a human being or an animal, of an effective amount of a pollen of preferably fermented flowers, or of its aqueous or organic extracts, in particular lipid extracts, for the desired cosmetic, pharmaceutical or therapeutic effect.
- This pollen can also be autoclaved at 120 ° C for 15 min in solution in water or an aqueous solution.
- this may be distilled water and sterile or not. It can be non-sterile water containing organic matter or a solution enriched with microorganisms with a content greater than several million per gram of water. These microorganisms such as yeasts, lactic flora such as the genus bifidus or lactobacillus or streptococcus, can come from isolation from fresh pollen or from other sources.
- the fermentation broth is added to the pollen at a concentration greater than 5% by weight, in practice generally an average concentration of between 20 and 40% by weight.
- This bath can be left macerated at a temperature between +10 and + 50 ° C optimally between about 25 ° C, that is to say at room temperature, at about 35 ° C, for a period of 1 h to 5 days, and generally 1 to 2 days.
- centrifuge-filtration techniques can be used to recover the pollen or to concentrate the new solution in microorganisms.
- microorganism contents greater than 1 million per gram, better at least 10 million per gram and even reach 1 billion per gram.
- This broth may contain autoclave or high pressure treated pollen, for example pascalisation at more than 3000 bars for more than 60 min.
- non-fermented but preferably fermented pollen it is also possible to stabilize the non-fermented but preferably fermented pollen, using different stabilization techniques, in particular a treatment at high pressures and / or an addition of acidic substances, advantageously authorized in cosmetics or in pharmacies such as citric acid or lemon juice, an essential citrus oil such as lemon, orange, grapefruit.
- acidic substances advantageously authorized in cosmetics or in pharmacies such as citric acid or lemon juice, an essential citrus oil such as lemon, orange, grapefruit.
- a basic composition comprising the following active ingredients:
- citric acid is first mixed with the essential oil of mint, then the complex of bacteria cultures inactivated is incorporated and mixed until homogeneous.
- This composition can be used as it is to constitute a cosmetic or pharmaceutical composition to obtain the effects previously described according to the invention and which are also demonstrated by the tests given below.
- This composition can be applied once, topically to the affected areas of the skin of a mammal, preferably a human.
- citric acid content of not more than about 3% by weight.
- composition according to the invention modified above to have a citric acid content of not more than approximately 3%, the complement possibly being constituted by a texture agent to obtain a cream which will be applied in a thick layer. on fabrics burnt by friction or by intense heat. From the first application, a visual improvement of these tissues is observed and after several applications, the appearance of a skin having an imprint essentially similar to the neighboring areas of skins which had not been subjected to burns.
- the composition of Example 8 below can also be applied.
- This mixture does not cause hyperemia and brightens the complexion.
- a basic composition is prepared comprising the following active ingredients: a) Inactivated culture complexes of bacteria of the genus bifldobacterium or of bacteria related to this genus at 30% commercially available and marketed by the German Company
- citric acid is first mixed with the essential oil of mint, then the complex of bacteria cultures inactivated is incorporated and mixed until homogeneous.
- composition can be used as it is to constitute a cosmetic or pharmaceutical composition to obtain the effects previously described according to the invention and which have also been demonstrated by tests of the type of those explained in Example 1.
- a composition is prepared comprising the following active ingredients: a) Inactivated culture complexes of bacteria of the genus bifldobacterium or of bacteria related to this genus at 30% commercially available and marketed by the German company Biodroga Cosmetic GmbH under the name Biorepair® approx. 54 g
- Example 1 The procedure is as described in Example 1, that is to say that the citric acid is first mixed with the essential oils, then the complex of inactivated cultures is added until complete homogenization.
- This composition can also be used as it is to constitute a cosmetic or pharmaceutical composition having the same activities as those of the composition of Example 1.
- Example 1 The effects described in Example 1 were effectively observed: a) On wrinkles and fine lines b) Tissue sagging c) The crumpled appearance due to drying d) Dark circles e) Pockets f) Treatment of scars g) Repair burned tissue h) Removal of pigmentation spots or redness on the skin i) Promotion of the growth or regrowth of integuments including nails, hair or body hair.
- Example 4 There is also a very significant improvement in the effects obtained for each of the activities compared to the effects obtained with the composition of Example 1. This improvement seems to be due to a combination of essential oil of mint and romain as well as to the proportion of citric acid.
- Example 4
- a composition can be prepared comprising the following active ingredients: a) Complexes of inactivated cultures of bacteria of the genus bifldobacterium or of bacteria related to this genus at 30% commercially available and marketed by the German Company
- Example 1 The procedure is as described in Example 1, that is to say that the citric acid is first mixed with the essential oils, then the complex of inactivated cultures is added until complete homogenization.
- This composition can also be used as it is to constitute a cosmetic or pharmaceutical composition having the same activities as those of the composition of Example 1.
- a composition can be prepared comprising the following active ingredients: a) Complexes of inactivated cultures of bacteria of the genus bifldobacterium or of bacteria related to this genus at 30% commercially available and marketed by the German Company
- Citric acid about 30 g
- Structural proteins, in particular soluble collagen about 15 g
- Example 1 For the preparation of this composition, the procedure is as in Example 1, that is to say first of all, citric acid is mixed with the essential oil, then the proteins, here soluble collagen, then finally the complex of cultures inactivated until complete homogeneity.
- This composition can also be used as it is to constitute a cosmetic or pharmaceutical composition exhibiting the activities described.
- This composition is applied to test each of the activities in an identical manner to Examples 1 and 2. There is a very good efficiency for each of the activities.
- composition according to the invention A composition is prepared having the following active ingredients: a) Inactivated culture complexes of bacteria of the genus bifldobacterium or of bacteria related to this genus at 30% commercially available and marketed by the German Company
- a composition is prepared having the following active ingredients: a) Inactivated culture complexes of bacteria of the genus bifldobacterium or of bacteria related to this genus at 30% commercially available and marketed by the German Company
- Structural protein hydrolyzate in particular collagen hydrolyzate about 5 g
- Example 1 To prepare this composition, the procedure is carried out as described in Example 1, that is to say by first mixing citric acid with the essential oil or with the essential oils, among the other ingredients, except the agent thickener, then the complex of inactivated cultures and finally the thickening agent.
- this composition can be used as it is as a cosmetic or pharmaceutical composition, then it will be noted that the presence of thickening agents makes it possible to obtain a chemical gumming effect as well as a mechanical effect promoting microcirculation in the capillaries close to the surface of the skin.
- Composition particularly suitable for repairing burned tissue
- composition has the following ingredients, as a percentage by weight: a) Inactivated culture complexes of bacteria of the genus bifldobacterium or of bacteria related to this genus at 30% commercially available and marketed by the German Company
- the mixing is carried out in the order indicated in the previous examples, the texture agent being added last.
- This composition is particularly suitable for treating tissues burnt by friction or by intense heat. From the first application, a visual improvement of these tissues is observed and after several applications, the appearance of skin having an imprint essentially similar to the neighboring areas of skins which had not been subjected to burns.
- composition according to the invention which is currently preferred is prepared, comprising the following active ingredients:
- composition according to the invention it is possible, before applying the composition according to the invention, to apply an moisturizing product to the entire face and then to make this mixture penetrate using a serum which penetrates very quickly and carries with it the active ingredients of the composition according to the invention.
- This serum may have the composition previously indicated in the present description.
- a composition is prepared having the following active ingredients, in percentage by weight:
- Component A about 70%
- Example 1 For the preparation of this composition, the procedure is as in Example 1, that is to say first of all, citric acid is mixed with the essential oil, then the soluble collagen and finally the inactivated culture complex. until complete homogeneity, then component B is added to component A thus formed.
- Example 11 according to the invention Cosmetic composition for the hair
- This composition is applied topically to the skin, for a week, there is no detectable anti-wrinkle effect, old scars. Likewise, there is no effect of repairing burned tissue, scarring, no effect on age spots or any effect of promoting growth or regrowth of the appendages.
- Example 14 of the invention The following cosmetic or pharmaceutical composition is prepared: a) Pollen from fermented sunflower flowers having a concentration of living or inactivated microorganisms of approximately 10 million per gram approximately 4.5%.
- This pollen consists of fresh pollen coming from the hive mixed with an aqueous solution enriched with lactic flora of the genus bifidus or lactobacillus or streptococcus with a content greater than 10 million microorganisms per gram of broth, broth representing 30% by weight of the pollen and after mixing the pollen with the broth, it is left to ferment or macerate at room temperature for 1 day.
- the fermented pollen is then collected by a conventional centrifugation-filtration technique which results in a concentration which allows a higher concentration of living or inactivated microorganisms, preferably around at least 10 million microorganisms per gram of concentrated products.
- Thickening agent such as polyvinyl alcohol or polyvinylpyrolydone 10%
- this composition the citric acid is first mixed with the essential oil, and then the other ingredients, except the gelling agent and the thickening agent, then the fermented pollen, with only part of the water, the remaining part of the water used to mix the carbopol to form a pregel which will then be added to the prepared solution with the other ingredients after adding the gelling agent, so as to finally constitute a gel, as is well known to those skilled in the art.
- this composition can be used as it is, as a cosmetic or pharmaceutical composition.
- Substance with thickening effect for example pectin or agar about 10%
- this composition To prepare this composition, first mix the citrus juice such as lemon juice with essential oil, then the other ingredients, except the thickening agent, then the fermented pollen and finally the thickening agent .
- this composition can be used as it is as a cosmetic or pharmaceutical composition with the same effects as those described in the previous example, but in a still reinforced manner.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002273512A CA2273512A1 (fr) | 1996-11-26 | 1997-11-26 | Composition cosmetique, pharmaceutique a base de cultures microbiennes en melange avec une huile essentielle et un acide |
US09/308,250 US6270811B1 (en) | 1996-11-26 | 1997-11-26 | Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid |
JP52436398A JP2001504510A (ja) | 1996-11-26 | 1997-11-26 | 精油及び酸と混合した微生物培養物を主成分とする薬用、化粧用組成物 |
EP97947137A EP0954279A2 (fr) | 1996-11-26 | 1997-11-26 | Composition cosmetique, pharmaceutique a base de cultures microbiennes en melange avec une huile essentielle et un acide |
AU52295/98A AU5229598A (en) | 1996-11-26 | 1997-11-26 | Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9614442A FR2756181B1 (fr) | 1996-11-26 | 1996-11-26 | Composition cosmetique, pharmaceutique a base de culture inactivee de bacteries bifidobacterium, d'huile de menthe et d'un acide |
FR96/14442 | 1996-11-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998023243A2 true WO1998023243A2 (fr) | 1998-06-04 |
WO1998023243A3 WO1998023243A3 (fr) | 1998-09-11 |
Family
ID=9498019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1997/002127 WO1998023243A2 (fr) | 1996-11-26 | 1997-11-26 | Composition cosmetique, pharmaceutique a base de cultures microbiennes en melange avec une huile essentielle et un acide |
Country Status (7)
Country | Link |
---|---|
US (1) | US6270811B1 (fr) |
EP (1) | EP0954279A2 (fr) |
JP (1) | JP2001504510A (fr) |
AU (1) | AU5229598A (fr) |
CA (1) | CA2273512A1 (fr) |
FR (1) | FR2756181B1 (fr) |
WO (1) | WO1998023243A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002029975A (ja) * | 2000-07-14 | 2002-01-29 | Pokka Corp | フリーラジカル消去剤 |
EP1236463A1 (fr) * | 2001-02-23 | 2002-09-04 | Chemisches Laboratorium Dr. Kurt Richter GmbH | Composition cosmétique à usage topique |
JP2004073050A (ja) * | 2002-08-13 | 2004-03-11 | Ryukyu Bio Resource Kaihatsu:Kk | 発酵処理植物の製造方法及び乳酸発酵処理物 |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605751B1 (en) | 1997-11-14 | 2003-08-12 | Acrymed | Silver-containing compositions, devices and methods for making |
EP1110555A1 (fr) | 1999-12-22 | 2001-06-27 | Societe Des Produits Nestle S.A. | Agent anti-adhesion de la flore pathogene de la peau |
ATE327779T1 (de) | 1999-12-30 | 2006-06-15 | Acrymed | Methode und zusammensetzungen für verbesserte abgabevorrichtungen |
EP1470820A4 (fr) * | 2001-12-28 | 2006-10-18 | Neochemir Inc | Compositions a base de dioxyde de carbone pour usage externe et procede de fabrication |
AU2003210311C1 (en) * | 2002-02-21 | 2009-04-02 | Societe Des Produits Nestle S.A. | Pet food composition for skin photoprotection |
US6953574B2 (en) * | 2002-06-21 | 2005-10-11 | Technology Commercialization, Inc. | Method for producing a fermented hydrolyzed medium containing microorganisms |
CN1678277B (zh) * | 2002-07-29 | 2010-05-05 | 艾克里麦德公司 | 治疗皮肤病的方法和组合物 |
US6921529B2 (en) * | 2002-07-29 | 2005-07-26 | Joseph C. Maley | Treatment modality and method for fungal nail infection |
US20040126449A1 (en) * | 2002-12-30 | 2004-07-01 | Gopa Majmudar | Topical composition and methods for treatment of aged or environmentally damaged skin |
FR2853242B1 (fr) * | 2003-04-01 | 2008-09-26 | Oreal | Procede cosmetique pour prevenir et/ou traiter les signes cutanes du vieillissement et/ou du stress utilisant des compositions appliquees sur des points d'acupuncture du visage et/ou du cou |
FR2855968B1 (fr) * | 2003-06-13 | 2012-11-30 | Coletica | Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques |
US20050036976A1 (en) * | 2003-08-12 | 2005-02-17 | Joel Rubin | Topical skin care composition |
US6936598B2 (en) * | 2003-11-21 | 2005-08-30 | Hill's Pet Nutrition, Inc. | Composition and method |
US7754677B2 (en) * | 2003-12-05 | 2010-07-13 | Hill's Pet Nutrition, Inc. | Composition and method for reducing diarrhea in a mammal |
US7374750B2 (en) * | 2004-05-14 | 2008-05-20 | Jennifer Albano | Probiotic containing anhydrous hair care composition |
FR2871061B1 (fr) * | 2004-06-04 | 2007-08-10 | Coletica Sa | Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif |
US8900624B2 (en) | 2004-07-30 | 2014-12-02 | Kimberly-Clark Worldwide, Inc. | Antimicrobial silver compositions |
US8361553B2 (en) | 2004-07-30 | 2013-01-29 | Kimberly-Clark Worldwide, Inc. | Methods and compositions for metal nanoparticle treated surfaces |
CN102783499A (zh) | 2004-07-30 | 2012-11-21 | 金伯利-克拉克环球有限公司 | 抗微生物的装置和组合物 |
US20060045894A1 (en) * | 2004-09-01 | 2006-03-02 | Vera Brown | Compound for neck skin firming |
WO2006034249A2 (fr) | 2004-09-20 | 2006-03-30 | Acrymed, Inc. | Compositions antimicrobiennes amorphes |
JP2008518042A (ja) * | 2004-10-07 | 2008-05-29 | アクセス ビジネス グループ インターナショナル エルエルシー | ローズマリー(Rosmarinusofficinalis)植物抽出物、アルピニア(Alpinia)植物抽出物、及びDNA修復酵素を含む組成物。 |
US8926952B2 (en) * | 2005-04-08 | 2015-01-06 | The Procter & Gamble Company | Methods of use of probiotic bifidobacteria for human beauty benefits |
US10953051B2 (en) | 2005-06-22 | 2021-03-23 | Novozymes A/S | Methods and means for protecting the skin against pathogenic microorganisms |
EP1736537A1 (fr) * | 2005-06-22 | 2006-12-27 | OrganoBalance GmbH | Procédés et moyens de protéger la peau contre les micro-organismes pathogènes |
JP4547320B2 (ja) * | 2005-09-08 | 2010-09-22 | 花王株式会社 | 養毛・育毛剤 |
JP4800015B2 (ja) * | 2005-11-22 | 2011-10-26 | 株式会社カロッツェリアジャパン | 皮膚炎発症抑制のための微生物培養物並びにそれらを用いた製品 |
US20070196301A1 (en) * | 2005-12-21 | 2007-08-23 | L'oreal | Cosmetic composition with a volumizing effect |
WO2007127236A2 (fr) | 2006-04-28 | 2007-11-08 | Acrymed, Inc. | Pansements pour site antimicrobien |
US7910127B2 (en) * | 2007-03-02 | 2011-03-22 | Biogaia Ab | Use of lactic acid bacteria for improving food lysine absorption of pet animals |
FR2913337A1 (fr) * | 2007-03-08 | 2008-09-12 | Oreal | Produit extemporane de soin a base d'un lyophilisat de microorganismes |
EP2207539A4 (fr) * | 2007-06-20 | 2013-03-27 | Univ Columbia | Compositions désinfectantes pour la peau ou pour des surfaces, contenant des substances d'origine végétale |
US9511040B2 (en) | 2007-06-20 | 2016-12-06 | The Trustees Of Columbia University In The City Of New York | Skin and surface disinfectant compositions containing botanicals |
US9981069B2 (en) | 2007-06-20 | 2018-05-29 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
US9687429B2 (en) * | 2007-06-20 | 2017-06-27 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositions containing low concentrations of botanicals |
US20090035228A1 (en) * | 2007-08-02 | 2009-02-05 | Shanta Modak | Skin and surface disinfectant compositions containing botanicals |
WO2008157092A1 (fr) * | 2007-06-20 | 2008-12-24 | The Trustees Of Columbia University In The City Of New York | Surfaces résistantes à la formation de biofilm |
JP5230212B2 (ja) * | 2008-01-31 | 2013-07-10 | 株式会社山田養蜂場本社 | メラニン生成抑制剤およびそれを含有する美白剤 |
US20110151031A1 (en) * | 2008-08-19 | 2011-06-23 | Dbc, Llc | Compositions and methods for utilizing the same |
JP2011026240A (ja) * | 2009-07-24 | 2011-02-10 | Api Co Ltd | 花粉荷を含有する育毛剤 |
US9968101B2 (en) | 2011-11-03 | 2018-05-15 | The Trustees Of Columbia University In The City Of New York | Botanical antimicrobial compositions |
DK2773334T3 (da) | 2011-11-03 | 2019-12-09 | Univ Columbia | Sammensætning med forlænget antimikrobiel aktivitet |
FR2982151B1 (fr) * | 2011-11-09 | 2014-01-24 | Oreal | Acide gras mono-insature pour le soin des ongles |
FR2982150B1 (fr) | 2011-11-09 | 2016-05-20 | Oreal | Acide gras mono-insature pour le soin des ongles |
TW201330856A (zh) | 2011-12-06 | 2013-08-01 | Univ Columbia | 廣效性的天然防腐組成物 |
FR2989002B1 (fr) * | 2012-04-10 | 2015-05-15 | Beepratte Lab | Compositions a base de probiotiques et d'un complexe beepollen/argile, leur preparation et leurs utilisations en nutrition et therapeutique |
FR2999932B1 (fr) | 2012-12-21 | 2020-01-31 | Société des Produits Nestlé S.A. | Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine |
FR2999931A1 (fr) | 2012-12-21 | 2014-06-27 | Oreal | Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine |
FR3005411B1 (fr) | 2013-05-07 | 2016-09-30 | Laboratoires Inneov | Association d'actifs pour une administration par voie orale pour ameliorer la qualite des ongles. |
EP3033072B1 (fr) * | 2013-08-12 | 2020-07-22 | Decima Health Limited | Plateforme de réaction et procédé de production de substances à base de pollen en combinaison avec de la cire d'abeilles et leurs utilisations |
US10434123B2 (en) | 2013-08-12 | 2019-10-08 | Decima Health Limited | Reaction platform and method for making pollen based materials and uses thereof |
KR101827775B1 (ko) * | 2016-04-18 | 2018-02-09 | 건국대학교 산학협력단 | 효소 식품 및 콜라겐을 유효성분으로 함유하는 갱년기 여성 눈썹 육모 및 손톱 개선용 조성물 |
KR101850770B1 (ko) * | 2017-09-14 | 2018-04-20 | 건국대학교 산학협력단 | 효소 식품 및 콜라겐을 유효성분으로 함유하는 갱년기 여성 손톱 개선용 조성물 |
JP6572337B2 (ja) * | 2018-02-28 | 2019-09-04 | 株式会社ファンケル | マイオカイン産生促進用組成物 |
US20200368146A1 (en) * | 2019-05-22 | 2020-11-26 | Mary Ahern | Method of cosmetic preservation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2222088A1 (en) * | 1973-03-23 | 1974-10-18 | Lancant Gregoire | Skin massage cream without allergic props - contg. a mixture of lanol wax, essential oils, plant extracts and preservatives |
EP0043128A1 (fr) * | 1980-06-27 | 1982-01-06 | Chemisches Laboratorium Dr. Kurt Richter GmbH | Produits cosmétique |
FR2573651A1 (fr) * | 1984-11-23 | 1986-05-30 | Allorant Solange | Formule pour la regeneration du derme humain ou animal |
EP0297457A2 (fr) * | 1987-06-26 | 1989-01-04 | Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG | Agent cosmétique |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03167113A (ja) * | 1989-11-24 | 1991-07-19 | Mirubon:Kk | 養毛剤 |
JPH0710740A (ja) * | 1993-04-26 | 1995-01-13 | Meiji Milk Prod Co Ltd | メラニン生成抑制剤 |
JPH08217658A (ja) * | 1995-02-15 | 1996-08-27 | Kanebo Ltd | セラミド合成促進剤 |
JP3129646B2 (ja) * | 1996-01-19 | 2001-01-31 | 鐘紡株式会社 | セラミド合成促進剤 |
-
1996
- 1996-11-26 FR FR9614442A patent/FR2756181B1/fr not_active Expired - Fee Related
-
1997
- 1997-11-26 AU AU52295/98A patent/AU5229598A/en not_active Abandoned
- 1997-11-26 JP JP52436398A patent/JP2001504510A/ja active Pending
- 1997-11-26 WO PCT/FR1997/002127 patent/WO1998023243A2/fr not_active Application Discontinuation
- 1997-11-26 EP EP97947137A patent/EP0954279A2/fr not_active Withdrawn
- 1997-11-26 US US09/308,250 patent/US6270811B1/en not_active Expired - Fee Related
- 1997-11-26 CA CA002273512A patent/CA2273512A1/fr not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2222088A1 (en) * | 1973-03-23 | 1974-10-18 | Lancant Gregoire | Skin massage cream without allergic props - contg. a mixture of lanol wax, essential oils, plant extracts and preservatives |
EP0043128A1 (fr) * | 1980-06-27 | 1982-01-06 | Chemisches Laboratorium Dr. Kurt Richter GmbH | Produits cosmétique |
FR2573651A1 (fr) * | 1984-11-23 | 1986-05-30 | Allorant Solange | Formule pour la regeneration du derme humain ou animal |
EP0297457A2 (fr) * | 1987-06-26 | 1989-01-04 | Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG | Agent cosmétique |
Non-Patent Citations (6)
Title |
---|
CHEMICAL ABSTRACTS, vol. 122, no. 16, 17 avril 1995 Columbus, Ohio, US; abstract no. 196567, SAWAI, YASUKO ET AL: "preparation of melanin inhibitor for manufacturing skin cosmetics" XP002039056 & JP 07 010 740 A (MEIJI MILK PROD CO LTD, JAPAN) * |
CHEMICAL ABSTRACTS, vol. 125, no. 22, 25 novembre 1996 Columbus, Ohio, US; abstract no. 284382, TANNO, OSAMU ET AL: "Topical compositions containing yeast extracts to promote ceramide biosynthesis and absorption" XP002061715 & JP 08 217 658 A (KANEBO LTD, JAPAN) * |
CHEMICAL ABSTRACTS, vol. 127, no. 14, 6 octobre 1997 Columbus, Ohio, US; abstract no. 195256, SASAKI, MINORU ET AL: "Rough skin-preventing cosmetics containing ceramide formation promoters" XP002061716 & JP 09 194 383 A (KANEBO, LTD., JAPAN) * |
H. FEY: "Wörterbuch der Kosmetik" 1985 , WISSENSCHALFTLICHE VERLAGSGESELLSCHAFT MBH , STUTTGART (DE) XP002039055 "Menthol" voir page 166-167 * |
H. FEY: "Wörterbuch der Kosmetik" 1985, STUTTGART DE, page 82 XP002061714 * |
M.C. MARTINI: "Actifs et Additifs en Cosmétologie" 1993, LONDRES NEW YORK, page 21 XP002061713 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002029975A (ja) * | 2000-07-14 | 2002-01-29 | Pokka Corp | フリーラジカル消去剤 |
EP1236463A1 (fr) * | 2001-02-23 | 2002-09-04 | Chemisches Laboratorium Dr. Kurt Richter GmbH | Composition cosmétique à usage topique |
US6790434B2 (en) | 2001-02-23 | 2004-09-14 | Chemisches Laboratorium Dr. Kurt Richter Gmbh | Topical cosmetic composition |
JP2004073050A (ja) * | 2002-08-13 | 2004-03-11 | Ryukyu Bio Resource Kaihatsu:Kk | 発酵処理植物の製造方法及び乳酸発酵処理物 |
Also Published As
Publication number | Publication date |
---|---|
JP2001504510A (ja) | 2001-04-03 |
FR2756181B1 (fr) | 1999-03-05 |
EP0954279A2 (fr) | 1999-11-10 |
FR2756181A1 (fr) | 1998-05-29 |
CA2273512A1 (fr) | 1998-06-04 |
AU5229598A (en) | 1998-06-22 |
US6270811B1 (en) | 2001-08-07 |
WO1998023243A3 (fr) | 1998-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0954279A2 (fr) | Composition cosmetique, pharmaceutique a base de cultures microbiennes en melange avec une huile essentielle et un acide | |
CA2395283C (fr) | Utilisation d'un extrait d'au moins un vegetal du genre vaccinium comme agent anti-glycation | |
FR2929511A1 (fr) | Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes. | |
FR2768927A1 (fr) | Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie | |
FR2935610A1 (fr) | Composition cosmetique ou dermatologique contenant un melange d'huiles essentielles et son utilisation, notamment pour le soin des peaux sensibles ou sensibilisees | |
FR2925326A1 (fr) | Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines | |
CA2908535A1 (fr) | Applications cosmetiques et pharmaceutiques de lactobacillus pentosus | |
FR2925325A1 (fr) | Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines | |
FR2925330A1 (fr) | Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines | |
WO2013072322A1 (fr) | Utilisation d'une association de trois principes actifs pour la reconstruction du tissu adipeux et la lutte contre les signes du vieillissement cutané | |
FR2934779A1 (fr) | Utilisation cosmetique d'un actif issu de ceratonia siliqua, principe actif et procede d'obtention. | |
FR2594847A1 (fr) | Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant | |
CA3173694C (fr) | Extrait de graines de moringa peregrina riche en 2,5-diformylfuran, son procede d'obtention et son utilisation dans des compositions cosmetiques | |
FR2913603A1 (fr) | Composition cosmetique destinee au soin de peaux agressees par un traitement esthetique tel qu'intervention chirurgicale,traitement lasers,dermabrasion,peeling. | |
FR3031458B1 (fr) | Extraits de salade, compositions et utilisations | |
WO1994002161A1 (fr) | Extraits bruts d'algues bleues, leurs procedes de preparation et leurs applications en cosmetologie et en dermatologie | |
FR3097762A1 (fr) | Utilisation d'un extrait hydro-alcoolique d'Onagre pour hydrater la peau et améliorer la fonction barrière | |
WO1994015626A9 (fr) | Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de vismia | |
FR2700268A1 (fr) | Composition cosmétique ou pharmaceutique, notamment dermatologique, contenant un extrait de Vismia. | |
FR2759910A1 (fr) | Compositions cosmetiques ou dermopharmaceutiques pour le raffermissement du buste, la stimulation du systeme capillaire et l'inhibition ou systeme pileux, contenant des extraits de kigelia africana | |
WO1997045099A1 (fr) | Utilisation de diterpenoides furanoides de labdane pour la preparation de compositions cosmetiques ou pharmaceutiques et de milieux de culture de cellules de peau | |
FR3052070B1 (fr) | Soin cutane oral d'origine naturelle protegeant contre les effets attaques exterieures et regenerant par l'activation de l'expression genique des facteurs de croissance epidermique (egf) | |
FR2945213A1 (fr) | Compositions cosmetiques et dermatologiques et dermatologiques a base d'extrait de silene. | |
FR2814063A1 (fr) | Composition cosmetique pour le soin des levres | |
FR3018685B1 (fr) | Applications cosmetiques et pharmaceutiques de la salicaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997947137 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2273512 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09308250 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 524363 Kind code of ref document: A Format of ref document f/p: F |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997947137 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997947137 Country of ref document: EP |